Missing injections, inconsistent weekly dosing, or premature discontinuation due to side effects all undermine tirzepatide's effect
This telehealth model addresses several access barriers that patients commonly face, including geographic limitations, scheduling constraints, and specialist availability
Usman F, Shah HS, Zaib S, Manee S, Mudassir J, Khan A, et al
If it is dispensed through a clinic or health care provider, it is more likely to be safe and effective. As for brand-name Wegovy, the shortage has been resolved, so this brand-name weight loss medication (made by Novo Nordisk) should now be available at a pharmacy near you
3.3.2 Harms: Risk of Ketoacidosis: The major concern is the development of diabetic ketoacidosis (DKA), including euglycemic DKA